Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN)
CUSIP: G1281K122
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Ordinary shares, par value $0.0135 per share
- Shares outstanding
- 3,320,313
- Total 13F shares
- 281,657
- Share change
- +45,477
- Total reported value
- $228,588
- Price per share
- $0.81
- Number of holders
- 6
- Value change
- +$32,523
- Number of buys
- 3
- Number of sells
- 1
Quarterly Holders Quick Answers
What is CUSIP G1281K122?
CUSIP G1281K122 identifies SLXN - Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP G1281K122:
Top shareholders of SLXN - Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. |
13D/G
|
— |
4.9%
|
456,531
|
$424,574 | +$109,304 | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13D/G
13F
|
THE GOLDMAN SACHS GROUP, INC. · Company |
2.4%
|
211,945
|
$197,109 | +$92,724 | 31 Mar 2025 | |
| INTRACOASTAL CAPITAL, LLC |
13D/G
|
Mitchell P. Kopin |
5%
|
209,827
|
$195,139 | $0 | 15 Jan 2025 | |
| Wildcat Capital Management, LLC |
13F
13D/G
3/4/5
|
Company · 10%+ Owner |
1.3%
from 13D/G
|
113,428
|
$124,771 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
2.2%
|
72,874
|
$80,161 | — | 31 Mar 2025 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
—
class O/S missing
|
743,475
|
$56,876 | — | 31 Mar 2025 | |
| MEYER HANDELMAN CO |
13F
|
Company |
0.99%
|
32,967
|
$36,264 | — | 31 Mar 2025 | |
| LINDEN ADVISORS LP |
13F
|
Company |
—
class O/S missing
|
337,500
|
$23,591 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0.49%
|
16,411
|
$18,052 | — | 31 Mar 2025 | |
| ARISTEIA CAPITAL, L.L.C. |
13F
|
Company |
—
class O/S missing
|
236,546
|
$16,546 | — | 31 Mar 2025 | |
| Hartree Partners, LP |
13F
|
Company |
—
class O/S missing
|
182,355
|
$14,588 | — | 31 Mar 2025 | |
| CLEAR STREET LLC |
13F
|
Company |
—
class O/S missing
|
145,165
|
$11,105 | — | 31 Mar 2025 | |
| SECURITY BENEFIT LIFE INSURANCE CO /KS/ |
13F
|
Company |
—
class O/S missing
|
150,000
|
$10,515 | — | 31 Mar 2025 | |
| Kepos Capital LP |
13F
|
Company |
—
class O/S missing
|
100,000
|
$8,000 | — | 31 Mar 2025 | |
| PERISCOPE CAPITAL INC. |
13F
|
Company |
—
class O/S missing
|
87,169
|
$6,668 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
—
class O/S missing
|
75,302
|
$5,761 | — | 31 Mar 2025 | |
| Yakira Capital Management, Inc. |
13F
|
Company |
—
class O/S missing
|
75,000
|
$5,738 | — | 31 Mar 2025 | |
| PICTON MAHONEY ASSET MANAGEMENT |
13F
|
Company |
—
class O/S missing
|
57,175
|
$4,000 | — | 31 Mar 2025 | |
| Context Capital Management, LLC |
13F
|
Company |
—
class O/S missing
|
51,183
|
$3,915 | — | 31 Mar 2025 | |
| TENOR CAPITAL MANAGEMENT Co., L.P. |
13F
|
Company |
—
class O/S missing
|
50,000
|
$3,825 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
—
class O/S missing
|
51,801
|
$3,631 | — | 31 Mar 2025 | |
| GABELLI & Co INVESTMENT ADVISERS, INC. |
13F
|
Company |
—
class O/S missing
|
38,150
|
$2,918 | — | 31 Mar 2025 | |
| Neuberger Berman Group LLC |
13F
|
Company |
—
class O/S missing
|
31,552
|
$2,414 | — | 31 Mar 2025 | |
| GABELLI FUNDS LLC |
13F
|
Company |
—
class O/S missing
|
30,496
|
$2,333 | — | 31 Mar 2025 | |
| DUPONT CAPITAL MANAGEMENT CORP |
13F
|
Company |
—
class O/S missing
|
32,500
|
$2,278 | — | 31 Mar 2025 | |
| Mint Tower Capital Management B.V. |
13F
|
Company |
—
class O/S missing
|
25,000
|
$2,000 | — | 31 Mar 2025 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
—
class O/S missing
|
16,000
|
$1,224 | — | 31 Mar 2025 | |
| RIVERNORTH CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
14,999
|
$1,147 | — | 31 Mar 2025 | |
| Saba Capital Management, L.P. |
13F
|
Company |
—
class O/S missing
|
11,937
|
$835 | — | 31 Mar 2025 | |
| COBBLESTONE CAPITAL ADVISORS LLC /NY/ |
13F
|
Company |
—
class O/S missing
|
10,000
|
$765 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
mixed-class rows
|
610
mixed-class rows
|
$558 | — | 31 Mar 2025 | |
| Ilan Shiloah |
3/4/5
|
Director |
—
class O/S missing
|
387,883
|
— | — | 15 Aug 2024 |
Institutional Holders of Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN) as of Q2 2025
As of 30 Jun 2025,
Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN) was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
281,657 shares.
The largest 6 holders included
Wildcat Capital Management, LLC, UBS Group AG, MEYER HANDELMAN CO, Virtu Financial LLC, StoneX Group Inc., and BANK OF AMERICA CORP /DE/.
This page lists
6
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
5
Q2 2025 holders
6
Holder diff
1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.